Home > Insider Trading > Filing (0001127602-13-026729)

Filing Details

Accession Number:: 0001127602-13-026729
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-05 19:33:50
Reporting Period:: 2013-09-04

Filing Date:: 2013-09-05
Accepted Time:: 2013-09-05 19:33:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
318154	Amgen Inc	AMGN	Biological Products, (No Disgnostic Substances) (2836)	953540776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555508	Madhavan Balachandran	One Amgen Center Drive Thousand Oaks CA 91320-1799	Evp, Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-04	18,000	$58.43	59,133	No	4	M	Direct
Common Stock	Acquisiton	2013-09-04	18,000	$0.00	52,851	No	5	G	Indirect	By Family Trust
Common Stock	Disposition	2013-09-04	18,000	$0.00	41,133	No	5	G	Direct
Common Stock	Disposition	2013-09-04	18,000	$112.76	34,851	No	4	S	Indirect	By Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	5	G	Indirect	By Family Trust
No	5	G	Direct
No	4	S	Indirect	By Family Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nqso (Right to Buy)	Disposition	2013-09-04	18,000	$0.00	18,000	$58.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,000	2011-04-26	2020-04-26	No	4	M	Direct

Footnotes

These shares are being transferred to the reporting person's Family Trust.
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 875 RSUs which fully vest on 4/26/2014; 3,015 RSUs which vest in one installment of 1,485 on 4/25/2014 and one installment of 1,530 on 4/25/2015; 2,512 RSUs which vest in three installments of 828, 829 and 855 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 26,634 RSUs which vest in two equal installments of 8,789 each on 7/31/2014 and 7/31/2015 and one installment of 9,056 on 7/31/2016; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 620 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
The price reported is an average price. The prices ranged from $112.66 to $112.90 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.